[Essential hypertension, dementia, and antihypertensive therapy in geriatric patients]

Area of Science:

• Neurology
• Cardiology
• Geriatrics

Background:

• Dementia pathogenesis is complex, with blood pressure emerging as a significant factor.
• Cognitive disorders and dementia pose a growing public health challenge, especially in aging populations.
• Antihypertensive therapy is a cornerstone in managing cardiovascular health and may impact cognitive function.

Purpose of the Study:

• To review current understanding of dementia pathogenesis and the role of blood pressure.
• To evaluate the efficacy of antihypertensive therapy in preventing cognitive decline and dementia.
• To analyze the effects of various antihypertensive drug classes on cognitive function.

Main Methods:

• Review of prospective cohort studies on antihypertensive therapy and dementia risk.
• Analysis of placebo-controlled trials in elderly patients with cerebrovascular complications.
• Synthesis of data from meta-analyses investigating antihypertensive treatment and cognitive outcomes.
• Examination of the impact of diuretics, calcium antagonists, ACE inhibitors, and ARBs on cognition.

Main Results:

• Evidence suggests a link between blood pressure levels and dementia development.
• Antihypertensive therapy demonstrates potential in reducing the risk of cognitive disorders and dementia.
• Different classes of antihypertensive agents may have varying effects on cognitive function.

Conclusions:

• Blood pressure management is crucial for dementia prevention strategies.
• Antihypertensive therapy is a viable approach for mitigating dementia risk, especially in vulnerable populations.
• Further research is warranted to elucidate the specific mechanisms and optimal use of antihypertensives for cognitive health.